GlobeImmune

Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases.

HQ location

Louisville, United States

Website

globeimmune.com

Launch date

1995

Employees

Market cap

Enterprise value

($7m)

Share price

$0.00 GBIM

https://twitter.com/globeimmunenews https://www.linkedin.com/company/globeimmune-inc.

Authorizing premium user...